Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

1,194.35 -39.32 (-3.19%)
Streaming Delayed Price Updated: 9:41 AM EDT, Aug 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
99 100 Next >
News headline image
Members of Congress Bought These 5 Stocks—Should You? ↗
Via MarketBeat
Airlines Take Flight While Oil Burns: Markets Edge Higher Amid Middle East Tensions ↗
Via Chartmill
News headline image
Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Zoetis (NYSE:ZTS)
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the branded pharmaceuticals stocks, including Zoetis (NYSE:ZTS) and its peers. Looking ... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Better Weight Loss Drug Stock Buy: Eli Lilly vs Viking Therapeutics ↗
Each of these companies could benefit from this high-growth market over time. 
Via The Motley Fool
News headline image
Top 2 S&P 500 Stocks to Watch This Week After Hims & Hers Stock's Surprise Move ↗
These companies are benefiting from a tidal wave of demand for new weight-loss drugs. 
Via The Motley Fool
Topics Stocks
News headline image
Stock Market Today, March 17: Markets Edge Upwards as Fed Meeting Opens ↗
Today, March 17, 2026, selective tech gains helped lift the Nasdaq even as oil prices and geopolitical tensions stayed elevated. 
Via The Motley Fool
Topics Economy Stocks
News headline image
Why Eli Lilly (LLY) Shares Are Plunging Today
What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 6.3% in the afternoon session after investment bank HSBC downgraded the stoc... 
Via StockStory
News headline image
Worried the AI Hype Won't Last? These Dividend Stocks Offer Safer Exposure ↗
You don't have to go all in to profit from AI. 
Via The Motley Fool
Topics Artificial Intelligence
Which S&P500 stocks are moving on Tuesday? ↗
Via Chartmill
News headline image
LLY Shares Dive On Analyst Downgrade Citing Obesity Market Overestimation Concerns, But Retail Dismisses ‘Absurd’ Selloff ↗
The analyst’s new price target represents a potential downside of about 14% from the stock’s last closing price on Monday. 
Via Stocktwits
Tuesday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
News headline image
Why Eli Lilly Stock Just Dropped ↗
Eli Lilly's stock price is based on growth rates that might fall short. 
Via The Motley Fool
News headline image
Eli Lilly Analyst Flags Overhyped Obesity Drug Expectations ↗
HSBC downgrades Eli Lilly to reduce, citing pricing pressure, rising competition, and overestimated obesity drug market growth expectations. 
Via Benzinga
Tuesday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
News headline image
This Promising GLP-1 Drug Could Give Novo Nordisk Investors Renewed Hope for the Stock ↗
Novo Nordisk recently announced promising trial results for one of its GLP-1 drugs in development. 
Via The Motley Fool
News headline image
Should You Avoid Pfizer? Here's the Key Risk to Watch ↗
Pfizer has reached a turning point. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Is There Too Much Bullishness Priced Into Eli Lilly's Stock Price? ↗
Eli Lilly's stock is down this year, and its high valuation may be a big reason why. 
Via The Motley Fool
News headline image
Merck & Co. Trades Ex-Dividend as Healthcare Emerges as a Volatility Hedge in 2026
Amidst a backdrop of mounting geopolitical tensions and sharp swings in the broader indices, pharmaceutical giant Merck & Co. (NYSE: MRK) officially trades ex-dividend today, March 16, 2026. Investors... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Why the Novo Nordisk and Hims & Hers Deal Is a Win for Both Stocks ↗
The drama and uncertainty around Novo Nordisk and Hims & Hers Health might finally be ending. 
Via The Motley Fool
News headline image
Eli Lilly's Eczema Drug Shows Strong Skin Clearance In Phase 3 Pediatric Trial ↗
Eli Lilly's Phase 3 results for Ebglyss in children with severe eczema, shows skin clearance and itch relief in trial patients. 
Via Benzinga
News headline image
3 Companies at the Forefront of the GLP-1 Pill Wars ↗
Via MarketBeat
News headline image
3 Quality Compounders to Own for Decades
Quality compounders are flywheels. Said differently, they’re businesses that generate heaps of profits and consistently reinvest them to produce even more pr... 
Via StockStory
News headline image
This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares ↗
This biotech firm develops therapies targeting cystic fibrosis, with shares up nearly 90% year-over-year as of the latest filing. 
Via The Motley Fool
News headline image
This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share ↗
RAPT Therapeutics develops oral therapies for cancer and inflammation, with key drug candidates currently in clinical trials. 
Via The Motley Fool
News headline image
3 Stocks That Could Be Next to Announce a Stock Split ↗
Via MarketBeat
News headline image
Eli Lilly’s Employer Push Could Unlock New GLP-1 Demand ↗
Via MarketBeat
News headline image
Is Eli Lilly's Weight Loss Empire in Trouble? ↗
It won't be easy to knock the company off its pedestal. 
Via The Motley Fool
News headline image
The Great Rotation: Investors Retreat to Defensive Fortresses as 2026 Market Volatility Bites
As the first quarter of 2026 unfolds, the euphoric bull market that defined the mid-2020s has hit a formidable wall of uncertainty. A potent cocktail of geopolitical instability in the Middle East and... 
Via MarketMinute
Topics Economy Stocks
News headline image
Flight to Quality: JPMorgan and Eli Lilly Emerge as Defensive Anchors Amid Geopolitical Storm
In a day marked by heightened global tensions and a sharp spike in energy prices, the U.S. equity markets witnessed a decisive "Great Rotation" as investors abandoned high-growth technology names in... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
The Real Reason Eli Lilly Is Pouring $3 Billion Into China ↗
Via MarketBeat
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.